Cargando…
Safety and effectiveness of recombinant human growth hormone replacement in postoperative craniopharyngioma children
Autores principales: | Zheng, Zhang-qian, Zhi, Di-jing, Shen, Shui-xian, Luo, Fei-hong, Zhao, Zhu-hui, Lu, Zhong, Ye, Rong, Cheng, Ruo-qian, Li, Xiao-jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850421/ http://dx.doi.org/10.1186/1687-9856-2013-S1-P63 |
Ejemplares similares
-
LTBK-02. Safety of growth hormone replacement therapy in childhood craniopharyngioma
por: van Schaik, Jiska, et al.
Publicado: (2022) -
Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma
por: Miao, Yuqi, et al.
Publicado: (2023) -
Risk Factor and Replacement Therapy Analysis of Pre- and Postoperative Endocrine Deficiencies for Craniopharyngioma
por: Cheng, Lidong, et al.
Publicado: (2023) -
Metabolic Effects of Recombinant Human Growth Hormone Replacement Therapy on Juvenile Patients after Craniopharyngioma Resection
por: Li, Shuying, et al.
Publicado: (2022) -
Blood Lipid Disorders in Post-Operative Craniopharyngioma Children and Adolescents and the Improvement with Recombinant Human Growth Hormone Replacement
por: Du, Han-Ze, et al.
Publicado: (2023)